Trade NBIX

-

00:00:00

Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company’s portfolio includes treatments for tardive dyskinesia, Parkinson’s disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive dyskinesia. The company’s commercial products include ONGENTYS, a catechol-O-methyltransferase inhibitor used as an adjunct therapy to levodopa/DOPA decarboxylase inhibitors for patients with Parkinson’s disease; ORILISSA for the management of moderate to severe endometriosis pain in women; and ORIAHNN, a non-surgical oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. Its product candidates in clinical development include NBI-921352 for treating pediatric patients, as well as adult focal epilepsy indications; and NBI-827104 to treat rare pediatric epilepsy and essential tremor. The company’s products in clinical development also comprise NBI-1065845 for the treatment of major depressive disorder; NBI-1065846 for treating anhedonia in major depressive disorder; and NBI-118568 for the treatment of schizophrenia. It has license and collaboration agreements with Heptares Therapeutics Limited; Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL ” Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; and AbbVie Inc. Neurocrine Biosciences, Inc. was incorporated in 1992 and is headquartered in San Diego, California.
Read More

NBIX
Trading Specifications

Digits

2

Point

0.01

Spread

floating

Contract Size

1

Volume Min

1

Volume Max

10,000

Volume Step

1

Swap Long

-2.41 In points

Swap Short

-1.40 In points
Available on

MT5, TradingView

Last update at December 1, 21:09 GMT+2.

*Data on this page is sourced from our MetaTrader 5 server using Prime Account pricing

NBIX
Economic Calendar

04:00 AM -
04:30 AM
ISM Manufacturing PMI
2023-12-02
United States of America
1D Change

1.358%

Why BlackBull Markets?

26k+

Tradable Assets

1:500

Leverage up to

Regulated

Multi-Regulated

24/7

Customer Support

$0

No Minimum Deposit

Latest News

Are OPEC+ 2024 voluntary cuts enough to support oil prices?

Few companies are as closely tied to their leaders as Berkshire is to Warren Buffett and was to Charlie Munger. Munger's recent passing, who served as Berkshire's vice chairman since 1978, signifies the end of an era for the company....

Will Berkshire Hathaway investors panic when Warren Buffet passes away?

Few companies are as closely tied to their leaders as Berkshire is to Warren Buffett and was to Charlie Munger. Munger's recent passing, who served as Berkshire's vice chairman since 1978, signifies the end of an era for the company....

Morgan Stanley and BofA’s 2024 EUR/USD Predictions

Morgan Stanely has released what they call their top trade for 2024, and it is the exact opposite of Bank of America’s call. Analysts at Morgan Stanley think selling EUR/USD around the current level of 1.10 is the trade to make...

Gold’s Outlook: Beyond $2,000 with Eyes on Powell’s Address

Gold reclaimed the US$2,000 threshold yesterday, marking its return to this level for the first time since May, after the US dollar weakened against most major currencies on Monday. The US dollar is now on track for its largest monthly...
Join Now